5 Healthcare Stocks to Invest In Today According to Stanley Druckenmiller

4. AbCellera Biologics Inc. (NASDAQ:ABCL)

Duquesne Family Office’s Stake Value: $9.4 million

Percentage of Duquesne Family Office’s 13F Portfolio: 0.34%

Number of Hedge Fund Holders: 18

AbCellera Biologics Inc. (NASDAQ:ABCL) is a Canadian biotechnology firm headquartered in Canada. It takes a unique approach to drug development, via searching a database of natural immune systems for finding new antibodies which can be developed into drugs.

For its fiscal Q4, AbCellera Biologics Inc. (NASDAQ:ABCL) raked in $139 million in revenue and $0.19 in GAAP EPS, beating analyst estimates for both metrics. Piper Sandler lowered its price target to $28 from $33 in February 2022, outlining that the company has reduced the pace of its program selectivity.

Duquesne Family Office held 659,750 AbCellera Biologics Inc. (NASDAQ:ABCL) shares as the fourth quarter of last year came to an end. These were worth $9.4 million and they represented 0.34% of its investment portfolio. Insider Monkey took a look at 924 hedge funds holdings for Q4 2021 and discovered that 18 had bought the company’s shares.

Julian Baker and Felix Baker’s Baker Bros. Advisors is AbCellera Biologics Inc. (NASDAQ:ABCL) ‘s largest investor. It has a $149 million stake that comes via 10 million shares.